PTC Therapeutics resumed with Buy from Neutral at UBS
PremiumThe FlyPTC Therapeutics resumed with Buy from Neutral at UBS
25d ago
PTC Therapeutics price target raised to $64 from $62 at Cantor Fitzgerald
Premium
The Fly
PTC Therapeutics price target raised to $64 from $62 at Cantor Fitzgerald
1M ago
PTC Therapeutics price target lowered to $51 from $53 at JPMorgan
Premium
The Fly
PTC Therapeutics price target lowered to $51 from $53 at JPMorgan
1M ago
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
PremiumPress ReleasesPTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
1M ago
Is PTCT a Buy, Before Earnings?
Premium
Pre-Earnings
Is PTCT a Buy, Before Earnings?
1M ago
PTC Therapeutics submits sepiapterin NDA to U.S. FDA
Premium
The Fly
PTC Therapeutics submits sepiapterin NDA to U.S. FDA
2M ago
PTC Therapeutics Faces EMA Rejection, Seeks Re-examination
PremiumCompany AnnouncementsPTC Therapeutics Faces EMA Rejection, Seeks Re-examination
3M ago
PTC Therapeutics announces CHMP maintains Translarna negative opinion
Premium
The Fly
PTC Therapeutics announces CHMP maintains Translarna negative opinion
3M ago
JPMorgan smid & large cap biotech analysts hold analyst/industry conference call
Premium
The Fly
JPMorgan smid & large cap biotech analysts hold analyst/industry conference call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100